Lee JS, Song WS, Lim JW, et al
Assessing Thyroid Cancer Risk With GLP-1 Therapy Ariana Pelosci Russ Conroy Gary L
Hence, a peptide was designed by substituting the negatively charged residues D42, D48, D49, E51, E56, and D57 within the p53 TAD PEP with alanine to increase its binding affinity to FOXO4 FHD and enhance membrane penetration
In recent years it has been shown that lipotoxicity may induce the release of extracellular vesicles (EVs) and affects (and is affected by) hypoxia, both of which play important roles in the progression of NAFLD (Fig
While adjuvant therapy has an established role in stage III MUP, its role is unclear in stage IV MUP [10]